These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
421 related articles for article (PubMed ID: 15947208)
21. Andrographolide down-regulates hypoxia-inducible factor-1α in human non-small cell lung cancer A549 cells. Lin HH; Tsai CW; Chou FP; Wang CJ; Hsuan SW; Wang CK; Chen JH Toxicol Appl Pharmacol; 2011 Feb; 250(3):336-45. PubMed ID: 21134392 [TBL] [Abstract][Full Text] [Related]
22. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma. Huang SP; Wu MS; Shun CT; Wang HP; Hsieh CY; Kuo ML; Lin JT J Biomed Sci; 2005; 12(1):229-41. PubMed ID: 15864753 [TBL] [Abstract][Full Text] [Related]
23. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways. Li X; Wang X; Ye H; Peng A; Chen L Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678 [TBL] [Abstract][Full Text] [Related]
24. Mechanism of vascular endothelial growth factor expression mediated by cisplatin in human ovarian cancer cells. Zhong XS; Liu LZ; Skinner HD; Cao Z; Ding M; Jiang BH Biochem Biophys Res Commun; 2007 Jun; 358(1):92-8. PubMed ID: 17470361 [TBL] [Abstract][Full Text] [Related]
25. Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A. Detwiller KY; Fernando NT; Segal NH; Ryeom SW; D'Amore PA; Yoon SS Cancer Res; 2005 Jul; 65(13):5881-9. PubMed ID: 15994966 [TBL] [Abstract][Full Text] [Related]
26. Diosgenin induces hypoxia-inducible factor-1 activation and angiogenesis through estrogen receptor-related phosphatidylinositol 3-kinase/Akt and p38 mitogen-activated protein kinase pathways in osteoblasts. Yen ML; Su JL; Chien CL; Tseng KW; Yang CY; Chen WF; Chang CC; Kuo ML Mol Pharmacol; 2005 Oct; 68(4):1061-73. PubMed ID: 15998873 [TBL] [Abstract][Full Text] [Related]
28. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841 [TBL] [Abstract][Full Text] [Related]
29. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma. Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI; Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691 [TBL] [Abstract][Full Text] [Related]
30. MAPK and Akt act cooperatively but independently on hypoxia inducible factor-1alpha in rasV12 upregulation of VEGF. Sodhi A; Montaner S; Miyazaki H; Gutkind JS Biochem Biophys Res Commun; 2001 Sep; 287(1):292-300. PubMed ID: 11549290 [TBL] [Abstract][Full Text] [Related]
31. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Jiang BH; Agani F; Passaniti A; Semenza GL Cancer Res; 1997 Dec; 57(23):5328-35. PubMed ID: 9393757 [TBL] [Abstract][Full Text] [Related]
32. Delphinidin inhibits angiogenesis through the suppression of HIF-1α and VEGF expression in A549 lung cancer cells. Kim MH; Jeong YJ; Cho HJ; Hoe HS; Park KK; Park YY; Choi YH; Kim CH; Chang HW; Park YJ; Chung IK; Chang YC Oncol Rep; 2017 Feb; 37(2):777-784. PubMed ID: 27959445 [TBL] [Abstract][Full Text] [Related]
33. Liquiritigenin inhibits serum-induced HIF-1α and VEGF expression via the AKT/mTOR-p70S6K signalling pathway in HeLa cells. Xie SR; Wang Y; Liu CW; Luo K; Cai YQ Phytother Res; 2012 Aug; 26(8):1133-41. PubMed ID: 22170854 [TBL] [Abstract][Full Text] [Related]
34. 5,3'-Dihydroxy-6,7,4'-trimethoxyflavanone exerts its anticancer and antiangiogenesis effects through regulation of the Akt/mTOR signaling pathway in human lung cancer cells. Kim KM; Heo DR; Lee J; Park JS; Baek MG; Yi JM; Kim H; Bang OS Chem Biol Interact; 2015 Jan; 225():32-9. PubMed ID: 25446852 [TBL] [Abstract][Full Text] [Related]
35. Hypoxia-inducible factor 1alpha and antiangiogenic activity of farnesyltransferase inhibitor SCH66336 in human aerodigestive tract cancer. Han JY; Oh SH; Morgillo F; Myers JN; Kim E; Hong WK; Lee HY J Natl Cancer Inst; 2005 Sep; 97(17):1272-86. PubMed ID: 16145048 [TBL] [Abstract][Full Text] [Related]
36. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions. Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546 [TBL] [Abstract][Full Text] [Related]
37. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells. Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267 [TBL] [Abstract][Full Text] [Related]
39. A mycobacterial iron chelator, desferri-exochelin, induces hypoxia-inducible factors 1 and 2, NIP3, and vascular endothelial growth factor in cancer cell lines. Chong TW; Horwitz LD; Moore JW; Sowter HM; Harris AL Cancer Res; 2002 Dec; 62(23):6924-7. PubMed ID: 12460908 [TBL] [Abstract][Full Text] [Related]
40. Ascofuranone suppresses EGF-induced HIF-1α protein synthesis by inhibition of the Akt/mTOR/p70S6K pathway in MDA-MB-231 breast cancer cells. Jeong YJ; Cho HJ; Magae J; Lee IK; Park KG; Chang YC Toxicol Appl Pharmacol; 2013 Dec; 273(3):542-50. PubMed ID: 24096035 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]